New Cousteau-Linked...
Health Care: Drugs
ARCA biopharma Inc. (ABIO: NASDAQ)
$0.48 -0.02 | -3.81%
06/04/12 - 01:42 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.50 |
| 52 Week High | 2.45 |
| 52 Week Low | 0.37 |
| Avg. Daily Vol. (Mil) | 0.09 |
| Beta (3 year) | 2.18 |
| Share Related Items | |
| Mkt Cap (Mil) | 6.10 |
| Shares Out (Mil) | 12.18 |
| Float (Mil) | 10.48 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 7.10 |
| Current Ratio | 7.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 1.40 |
| Price/Cash Flow | -1.50 |
| Per Share Data | |
| Earnings | -0.41 |
| Sales | 0.00 |
| Book Value | 0.36 |
| Cash Flow | -0.33 |
| Business Summary | |
|---|---|
| ARCA biopharma, Inc. is a biopharmaceutical company whose focus is developing genetically-targeted therapies for cardiovascular diseases. | |
| General Information | |
| 8001 Arista Place
Suite 430 Broomfield, CO 80021 |
|
| www.arcabiopharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 11 | |
| CEO: Dr. Michael R. Bristow,M | |
| Short Interest | |
| Current Month (Mil) | 0.37 |
| Previous Month (Mil) | 0.45 |
| Short Interest Ratio (Days) | 8.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -92.10 |
| Return on Investments | -104.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ABIO
- Portfolio NameUser Type
- Userbuddy62370 Portfolio 1
- UserKumaran
- UserSUPRATRADE NEW-BUY LIST-240...
Latest ABIO Headlines from TheStreet
- InfoLogix, Netlist: Midday Volume Plays 05.17.10 | 01:05 pm
- Arca BioPharma Patent Deja Vu: BioBuzz 03.29.10 | 06:03 am
- Sirius XM, ARCA biopharma: Early Volume Plays 03.26.10 | 09:03 am
- Brazilian Telecom, Agria: Midday Volume Plays 11.24.09 | 01:11 pm
- ARCA, FortuNet: Midday Volume Plays 11.23.09 | 01:11 pm
- Funds Sell $4M Worth of Pain Therapeutics 06.11.09 | 09:06 am
- Ford, Deere, Cisco Systems Are Big Movers 06.01.09 | 05:06 pm
- FDA Wants ARCA To Run More Tests On Heart Drug 06.01.09 | 11:06 am
- The Second Dendreon Wave
05.18.09 | 02:05 pm
Press Releases for ABIO
- GencaroTM's Norepinephrine Lowering Likely Contributes To Its Effect In Atrial Fibrillation Prevention - Business Wire 03.26.12 | 12:03 pm
- GencaroTM Atrial Fibrillation Data Selected For Presentation At American College Of Cardiology 61st Annual Scientific Session & Expo - Business Wire 03.20.12 | 08:03 am
- ARCA Biopharma Announces Additional Patent Issued For Methods For Treatment With Bucindolol Based On Genotype Of Patient - Business Wire 01.19.12 | 08:01 am
- CEO Of ARCA Biopharma To Speak On Use Of Biomarkers And Implications Of Personalized Medicine At New Paradigms Conference On January 12, 2012 - Business Wire 01.05.12 | 08:01 am
- Dr. Michael Bristow, CEO, ARCA Biopharma (Photo: Business Wire) - Business Wire 12.30.11 | 08:12 am
- ARCA Biopharma Announces Private Placement Of $1.75 Million With Institutional Investors - Business Wire 12.22.11 | 08:12 am
- Kaplan Meier Curves By Beta-1 389 Arg/Gly Polymorphism. (Graphic: Business Wire) - Business Wire 11.16.11 | 11:11 am
- Dr. Michael Bristow, CEO, ARCA Biopharma (Photo: Business Wire) - Business Wire 11.11.11 | 08:11 am
- Two GencaroTM Atrial Fibrillation Abstracts Accepted For Presentation At The American Heart Association Scientific Sessions 2011 - Business Wire 08.10.11 | 08:08 am
- ARCA Biopharma Announces Planned Expansion Of Gencaro Development To Atrial Fibrillation - Business Wire 05.26.11 | 08:05 am
Partner Headlines for ABIO
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Top Percentage Gainers and Losers as of 2pm 05/13/11 (ABIO, GFRE, DDS, APL, DF, VRML, DAR, SWSH, ONTY, GS, RMBS, LPHI, GGS, CA, NVDA, IMRS, MNTX, MPG, GTY) - Benzinga 05.13.11 | 02:05 pm
- Morning Market Movers (ABIO, LBIX, CGNX, AEIS) - Benzinga 05.03.11 | 09:05 am
- UPDATE 1-Arca reaches agreement with FDA on heart-drug study - Reuters 05.17.10 | 09:05 am
- UPDATE 1-ARCA gets U.S. patent related to heart drug; shrs soar - Reuters 03.26.10 | 10:03 am
